Cholinergic modulation of nociceptive responses in vivo and neuropeptide release in vitro at the level of the primary sensory neuron
- 1 January 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Pain
- Vol. 107 (1) , 22-32
- https://doi.org/10.1016/j.pain.2003.09.022
Abstract
Muscarinic acetylcholine receptors (mAChRs) have been widely reported as pharmacological targets for the treatment of pain. However, most of these efforts have focused on CNS mAChRs and their role in modulating nociception at the level of the spinal cord. The present study examines the contrKeywords
This publication has 30 references indexed in Scilit:
- Muscarinic M2 receptors inhibit heat-induced CGRP release from isolated rat skinNeuroReport, 2001
- Stable expression and pharmacological properties of the human α7 nicotinic acetylcholine receptorEuropean Journal of Pharmacology: Molecular Pharmacology, 1995
- Muscarinic Receptors—Characterization, coupling and functionPharmacology & Therapeutics, 1993
- Selective neuronal glycoconjugate expression in sensory and autonomic ganglia: relation of lectin reactivity to peptide and enzyme markersJournal of Neurocytology, 1990
- Application of the formalin test to the study of orofacial pain in the ratNeuroscience Letters, 1989
- Control of transmitter release from the motor nerve by presynaptic nicotinic and muscarinic autoreceptorsTrends in Pharmacological Sciences, 1989
- The molecular basis of muscarinic receptor diversityTrends in Neurosciences, 1989
- Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genesNeuron, 1988
- Vasodilatory effects and coexistence of calcitonin gene‐related peptide (CGRP) and substance P in sensory nerves of cat dental pulpActa Physiologica Scandinavica, 1987
- Calcitonin gene-related peptide is a potent vasodilatorNature, 1985